Q3 EPS Forecast for Dolby Laboratories Boosted by Analyst

Dolby Laboratories, Inc. (NYSE:DLBFree Report) – Equities researchers at William Blair boosted their Q3 2025 earnings per share estimates for Dolby Laboratories in a research note issued on Wednesday, November 20th. William Blair analyst R. Schackart now forecasts that the electronics maker will post earnings of $0.52 per share for the quarter, up from their prior forecast of $0.43. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.67 per share.

Several other equities analysts have also recently weighed in on the company. StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Monday, November 18th. Rosenblatt Securities boosted their price objective on shares of Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Wednesday, November 20th. Finally, Barrington Research reiterated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Wednesday, November 20th.

Get Our Latest Report on Dolby Laboratories

Dolby Laboratories Trading Down 0.3 %

NYSE:DLB opened at $80.33 on Monday. The business’s fifty day moving average price is $74.50 and its 200 day moving average price is $75.96. The firm has a market capitalization of $7.66 billion, a price-to-earnings ratio of 29.64 and a beta of 0.98. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $90.06.

Dolby Laboratories announced that its board has approved a stock buyback plan on Wednesday, August 7th that authorizes the company to buyback $350.00 million in outstanding shares. This buyback authorization authorizes the electronics maker to repurchase up to 5% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 10th. Shareholders of record on Tuesday, December 3rd will be issued a $0.33 dividend. The ex-dividend date is Tuesday, December 3rd. This represents a $1.32 dividend on an annualized basis and a yield of 1.64%. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.30. Dolby Laboratories’s dividend payout ratio (DPR) is 48.71%.

Insiders Place Their Bets

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the sale, the chief executive officer now owns 83,721 shares in the company, valued at $6,205,400.52. The trade was a 25.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Peter C. Gotcher sold 6,079 shares of Dolby Laboratories stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $78.96, for a total transaction of $479,997.84. Following the sale, the director now owns 37,593 shares in the company, valued at approximately $2,968,343.28. This trade represents a 13.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 39.54% of the company’s stock.

Hedge Funds Weigh In On Dolby Laboratories

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Blue Trust Inc. boosted its holdings in shares of Dolby Laboratories by 398.8% in the 2nd quarter. Blue Trust Inc. now owns 414 shares of the electronics maker’s stock worth $35,000 after acquiring an additional 331 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in shares of Dolby Laboratories in the second quarter valued at $37,000. GAMMA Investing LLC raised its holdings in shares of Dolby Laboratories by 64.6% in the second quarter. GAMMA Investing LLC now owns 489 shares of the electronics maker’s stock valued at $39,000 after buying an additional 192 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its holdings in Dolby Laboratories by 192.4% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 576 shares of the electronics maker’s stock worth $46,000 after acquiring an additional 379 shares during the last quarter. Finally, First Horizon Advisors Inc. increased its position in Dolby Laboratories by 22.7% in the 3rd quarter. First Horizon Advisors Inc. now owns 790 shares of the electronics maker’s stock valued at $60,000 after acquiring an additional 146 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.